23:57 GMT08 July 2020
Listen Live
    Get short URL
    0 24

    The US Food and Drug Administration has approved the first 3D-printed pill, an epilepsy medicine called Spritam.

    The prescription tablet is the first 3D-printed product that the FDA has approved for internal human consumption.

    Previous tablets did not dissolve easily. The company behind Spritam, Aprecia Pharmaceuticals, said the new, 3D-printed version has porous layers that make it easily dissolvable while still reaching a high dosage level.

    Seizure medication is often large and difficult to swallow, particularly for the elderly and children, which makes Spritam a boon to those patients.

    "By combining 3DP technology with a highly-prescribed epilepsy treatment, Spritam is designed to fill a need for patients who struggle with their current medication experience," Aprecia CEO Don Wetherhold said in a statement.

    Spritam is expected to hit the market sometime in 2016.

    The pill is the latest in a series of healthcare products that utilize 3D printing, including jaw replicas, dental implants, and hip replacements, Time reported. Scientists are also developing 3D-printed tracheas, bones, ears, kidneys and skin.

    3D printing, medications, prescription medication, FDA, United States
    Community standardsDiscussion